Detalles de la búsqueda
1.
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Oncologist
; 25(10): e1457-e1463, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32608142
2.
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.
Cancer Immunol Immunother
; 68(3): 517-527, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30591959
3.
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
Cancer
; 123(17): 3367-3376, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28518219
4.
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin.
Invest New Drugs
; 33(6): 1187-96, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26403509
5.
Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.
Cancer Control
; 21(1): 57-62, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357742
6.
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer.
JCO Precis Oncol
; 8: e2400075, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754057
7.
Perspective: rethinking therapeutic strategies in oncology.
Front Oncol
; 13: 1335987, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38269024
8.
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis.
Cancer
; 118(9): 2525-31, 2012 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22028294
9.
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping.
JTO Clin Res Rep
; 2(4): 100151, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590008
10.
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
Lancet Respir Med
; 9(5): 467-475, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33096027
11.
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
J Thorac Oncol
; 15(12): 1919-1927, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32916308
12.
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
ESMO Open
; 5(5): e000799, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097651
13.
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
J Thorac Oncol
; 15(2): 266-273, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605794
14.
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(14): 3525-3536, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32193228
15.
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.
J Thorac Oncol
; 15(9): 1449-1459, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389639
16.
Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysis.
Immunotherapy
; 11(5): 407-428, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30712477
17.
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.
Cancer Immunol Res
; 7(12): 1903-1909, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31658994
18.
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies.
Clin Cancer Res
; 13(19): 5855-61, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17908979
19.
A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing.
Clin Cancer Res
; 13(3): 986-93, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17289894
20.
Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions.
Curr Treat Options Oncol
; 9(4-6): 300-12, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19266288